In the field of liver cancer treatment, EGCG exhibits a triple effect, inhibiting tumor proliferation, invasion, and angiogenesis by downregulating the MAPK/AKT/STAT3 signaling cascade. This evidence concerns the gene AKT1 and liver cancer.